1 / 30

HEART-LUNG TRANSPLANTATION

HEART-LUNG TRANSPLANTATION. Overall. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR. * Numbers may be low due to delayed reporting. HEART-LUNG TRANSPLANTATION ACTUARIAL SURVIVAL (1982-2001). Half-life = 2.8 years Conditional Half-life = 8.2 years. N=2,928. Survival (%).

deborah-mosley
Download Presentation

HEART-LUNG TRANSPLANTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEART-LUNG TRANSPLANTATION Overall

  2. NUMBER OF HEART-LUNG TRANSPLANTS REPORTED BY YEAR * Numbers may be low due to delayed reporting

  3. HEART-LUNG TRANSPLANTATIONACTUARIAL SURVIVAL (1982-2001) Half-life = 2.8 years Conditional Half-life = 8.2 years N=2,928 Survival (%)

  4. HEART-LUNG RECIPIENTSFunctional Status (April 1994 – December 2001)

  5. HEART-LUNG RECIPIENTSEmployment Status(U.S.: April 1994 – December 2001)

  6. HEART-LUNG RECIPIENTS: Rehospitalization Post-transplant(April 1994 - December 2001)

  7. HEART-LUNG TRANSPLANTATION Adult Recipients

  8. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS (1982-2001) “Other” includes cancer, LAM, OB, bronchiectasis, retransplant, sarcoidosis

  9. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS(1982-2001)

  10. DIAGNOSIS IN ADULT HEART-LUNG TRANSPLANTS BY ERA 1982-1990 1991-1995 1996-2001 “Other” includes OB (non-ReTX), Bronchiectasis, Sarcoidosis

  11. ADULT HEART-LUNG RECIPIENTS Induction ImmunosuppressionFor follow-ups between October 1999 and December 2001

  12. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Any Time During Follow-upFor follow-ups between October 1999 and December 2001

  13. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001

  14. ADULT HEART-LUNG RECIPIENTSMaintenance Immunosuppression at Time of Follow-upFor follow-ups between October 1999 and December 2001

  15. ADULT POST-HEART-LUNG TRANSPLANT MORBIDITYCumulative Incidence of Survivors(April 1994-December 2001)

  16. Freedom from CAV For Adult Heart-Lung Recipients(April 1994-December 2000)

  17. Freedom from Bronchiolitis Obliterans For Adult Heart-Lung Recipients(April 1994-December 2000)

  18. Freedom from Renal DysfunctionFor Adult Heart-Lung Recipients(April 1994-December 2000) * Renal dysfunction = Creatinine > 2.5 mg/dl, dialysis or renal transplant

  19. MALIGNANCY POST-HEART-LUNG TRANSPLANT FOR ADULTSCumulative Incidence for Survivors(April 1994-December 2001)

  20. Freedom from MalignancyFor Adult Heart-Lung Recipients(April 1994-December 2000)

  21. ADULT HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(1987-2001)

  22. HEART-LUNG TRANSPLANTATION Pediatric Recipients

  23. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTS (1982-2001)

  24. AGE DISTRIBUTION FOR DONORS OF PEDIATRIC HEART-LUNG RECIPIENTS(1982-2001)

  25. AGE DISTRIBUTION OF PEDIATRIC HEART-LUNG RECIPIENTSBy Year of Transplant Number of Transplants * Numbers may be low due to delayed reporting.

  26. NUMBER OF CENTERS REPORTING PEDIATRIC HEART-LUNG TRANSPLANTS * Numbers may be low due to delayed reporting.

  27. “Other” includes Alpha-1, Bronchiectasis, IPF and OB (non-ReTX) DIAGNOSIS IN PEDIATRIC HEART –LUNG TRANSPLANT RECIPIENTS (Age: 11-17 Years)

  28. PEDIATRIC HEART-LUNG TRANSPLANTATIONActuarial Survival(1982-2001) Comparison between 1-10 years and 11-17 years not significant

  29. PEDIATRIC HEART-LUNG TRANSPLANTATION Actuarial Survival by Era(1982-2001) Survival (%) No comparisons are statistically significant

  30. PEDIATRIC HEART-LUNG TRANSPLANT RECIPIENTS: Cause of Death(1987-2001)

More Related